General Information of the Protein
Protein ID
PT03126
Protein Name
Kelch-like ECH-associated protein 1
Secondarily
Protein Name
Cytosolic inhibitor of Nrf2
Kelch-like protein 19
Gene Name
KEAP1
Secondarily
Gene Name
INRF2
KIAA0132
KLHL19
Sequence
MQPDPRPSGAGACCRFLPLQSQCPEGAGDAVMYASTECKAEVTPSQHGNRTFSYTLEDHTKQAFGIMNELRLSQQLCDVTLQVKYQDAPAAQFMAHKVVLASSSPVFKAMFTNGLREQGMEVVSIEGIHPKVMERLIEFAYTASISMGEKCVLHVMNGAVMYQIDSVVRACSDFLVQQLDPSNAIGIANFAEQIGCVELHQRAREYIYMHFGEVAKQEEFFNLSHCQLVTLISRDDLNVRCESEVFHACINWVKYDCEQRRFYVQALLRAVRCHSLTPNFLQMQLQKCEILQSDSRCKDYLVKIFEELTLHKPTQVMPCRAPKVGRLIYTAGGYFRQSLSYLEAYNPSDGTWLRLADLQVPRSGLAGCVVGGLLYAVGGRNNSPDGNTDSSALDCYNPMTNQWSPCAPMSVPRNRIGVGVIDGHIYAVGGSHGCIHHNSVERYEPERDEWHLVAPMLTRRIGVGVAVLNRLLYAVGGFDGTNRLNSAECYYPERNEWRMITAMNTIRSGAGVCVLHNCIYAAGGYDGQDQLNSVERYDVETETWTFVAPMKHRRSALGITVHQGRIYVLGGYDGHTFLDSVECYDPDTDTWSEVTRMTSGRSGVGVAVTMEPCRKQIDQQNCTC
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Unclassified protein
Function
Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin ligase complex that regulates the response to oxidative stress by targeting NFE2L2/NRF2 for ubiquitination (PubMed:14585973, PubMed:15379550, PubMed:15572695, PubMed:15983046, PubMed:15601839). KEAP1 acts as a key sensor of oxidative and electrophilic stress: in normal conditions, the BCR(KEAP1) complex mediates ubiquitination and degradation of NFE2L2/NRF2, a transcription factor regulating expression of many cytoprotective genes (PubMed:15601839, PubMed:16006525). In response to oxidative stress, different electrophile metabolites trigger non-enzymatic covalent modifications of highly reactive cysteine residues in KEAP1, leading to inactivate the ubiquitin ligase activity of the BCR(KEAP1) complex, promoting NFE2L2/NRF2 nuclear accumulation and expression of phase II detoxifying enzymes (PubMed:19489739, PubMed:16006525, PubMed:17127771, PubMed:18251510, PubMed:29590092). In response to selective autophagy, KEAP1 is sequestered in inclusion bodies following its interaction with SQSTM1/p62, leading to inactivation of the BCR(KEAP1) complex and activation of NFE2L2/NRF2 (PubMed:20452972). The BCR(KEAP1) complex also mediates ubiquitination of SQSTM1/p62, increasing SQSTM1/p62 sequestering activity and degradation (PubMed:28380357). The BCR(KEAP1) complex also targets BPTF and PGAM5 for ubiquitination and degradation by the proteasome (PubMed:15379550, PubMed:17046835).
    Show/Hide
Uniprot ID
Primary ID:
Q14145

Secondarily ID:
B3KPD5
Q6LEP0
Q8WTX1
Q9BPY9
    Show/Hide
Ensembl ID
ENSG00000079999
HGNC ID
HGNC:23177
Subcellular Location
Cytoplasm
Nucleus
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000006 , HEK293
Compound ID Compound Name Compound Formula
CP0446048
(3S)-3-[5-fluoro-3-(1,2-thiazol-5-yl)pyridin-2-yl]-3-methoxy-5,5-dimethyl-6-oxocyclohexene-1-carbonitrile
   Show/Hide
C18H16FN3O2S
 1
1
EC50 = 2 nM
   TI
   LI
   LO
   TS
CP0575413
3-[5-fluoro-3-(1-methylpyrazol-4-yl)pyridin-2-yl]-3-methoxy-5,5-dimethyl-6-oxocyclohexene-1-carbonitrile
   Show/Hide
C19H19FN4O2
 1
1
EC50 = 2 nM
   TI
   LI
   LO
   TS
CP0538369
3-(3-bromo-5-fluoropyridin-2-yl)-3-methoxy-5,5-dimethyl-6-oxocyclohexene-1-carbonitrile
   Show/Hide
C15H14BrFN2O2
 1
1
EC50 = 6 nM
   TI
   LI
   LO
   TS
CP0391316
3-[5-fluoro-3-(2-methyl-1,3-thiazol-5-yl)pyridin-2-yl]-3-methoxy-5,5-dimethyl-6-oxocyclohexene-1-carbonitrile
   Show/Hide
C19H18FN3O2S
 1
1
EC50 = 7 nM
   TI
   LI
   LO
   TS
CP0569721
3-[3-(difluoromethoxy)-5-fluoropyridin-2-yl]-3-methoxy-5,5-dimethyl-6-oxocyclohexene-1-carbonitrile
   Show/Hide
C16H15F3N2O3
 1
1
EC50 = 8 nM
   TI
   LI
   LO
   TS
CP0547525
(5S)-5-[3-(difluoromethyl)pyridin-2-yl]-5-methoxy-8-oxospiro[2.5]oct-6-ene-7-carbonitrile
   Show/Hide
C16H14F2N2O2
 1
1
EC50 = 14 nM
   TI
   LI
   LO
   TS
CP0543914
5-[3-(difluoromethyl)-5-fluoropyridin-2-yl]-5-methoxy-8-oxospiro[2.5]oct-6-ene-7-carbonitrile
   Show/Hide
C16H13F3N2O2
 1
1
EC50 = 18 nM
   TI
   LI
   LO
   TS
CP0416251
3-methoxy-5,5-dimethyl-6-oxo-3-[3-(trifluoromethyl)pyridin-2-yl]cyclohexene-1-carbonitrile
   Show/Hide
C16H15F3N2O2
 1
1
EC50 = 24 nM
   TI
   LI
   LO
   TS
CP0484405
(3S)-3-[3-(difluoromethyl)-5-fluoropyridin-2-yl]-3-methoxy-5,5-dimethyl-6-oxocyclohexene-1-carbonitrile
   Show/Hide
C16H15F3N2O2
 1
1
EC50 = 33 nM
   TI
   LI
   LO
   TS
CP0469356
US11479539, Compound 22
   Show/Hide
C15H15BrN2O2
 1
1
EC50 = 45 nM
   TI
   LI
   LO
   TS
CP0471821
3-methoxy-5,5-dimethyl-3-[3-(1-methylpyrazol-4-yl)pyridin-2-yl]-6-oxocyclohexene-1-carbonitrile
   Show/Hide
C19H20N4O2
 1
1
EC50 = 56 nM
   TI
   LI
   LO
   TS
CP0467695
US11479539, Compound 25
   Show/Hide
C19H20N4O2
 1
1
EC50 = 70 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0144616
4-methoxy-N-[4-[(4-methoxyphenyl)sulfonylamino]naphthalen-1-yl]benzenesulfonamide
   Show/Hide
C24H22N2O6S2
 4
1 EC50 = 1460 nM
2 Kd = 500 nM
3 Kd = 1690 nM
4 Kd = 1700 nM
Clinical Information about the Protein
Target 1 ( Cysteines of Keap1 (KEAP1 Cysteines) )
Target Type Clinical trial Target